대추 추출물을 유효성분으로 함유하는 허혈성 뇌혈관질환의 예방 및 치료용 조성물
    1.
    发明授权
    대추 추출물을 유효성분으로 함유하는 허혈성 뇌혈관질환의 예방 및 치료용 조성물 有权
    组成包括ZIZIPHUS JUJUBA MILL的提取物。 用于预防和治疗ISCHEMIA损伤疾病的多种螺旋体

    公开(公告)号:KR100757207B1

    公开(公告)日:2007-09-10

    申请号:KR1020060088897

    申请日:2006-09-14

    CPC classification number: A61K36/725 A23V2200/322 A61K2236/331 A61K2236/333

    Abstract: A composition for prevention and treatment of ischemia cerebrovascular disease comprising the extract of Ziziphus jujuba MILL.(jujube) is provided to prevent damage of neuronal cells of hippocampus tissue CA1 region and inhibit apoptosis of neuronal cells without side effects. A composition for prevention and treatment of ischemia cerebrovascular disease comprises the extract of Ziziphus jujuba MILL. which is prepared by extracting with water, methanol, ethanol, butanol or a mixed solvent thereof, wherein the ischemia cerebrovascular disease is cerebral infarction, stroke, cerebral hemorrhage or subarachnoidal hemorrhage, and the composition is a pharmaceutical or health food composition formulated as powder, granule, tablet, capsule or drink.

    Abstract translation: 提供一种预防和治疗缺血性脑血管病的组合物,其包含枣子提取物(枣),以防止海马组织CA1区域的神经元细胞的损伤并抑制神经元细胞的凋亡而没有副作用。 一种用于预防和治疗缺血性脑血管病的组合物,其特征在于含有枣枣的提取物。 其是通过用水,甲醇,乙醇,丁醇或其混合溶剂萃取而制备的,其中所述缺血性脑血管病是脑梗塞,中风,脑出血或蛛网膜下腔出血,并且该组合物是配制成粉末的药物或保健食品组合物, 颗粒,片剂,胶囊或饮料。

    삼지구엽초 추출물을 포함하는 허혈성 뇌혈관질환 예방또는 개선용 조성물
    4.
    发明公开
    삼지구엽초 추출물을 포함하는 허혈성 뇌혈관질환 예방또는 개선용 조성물 有权
    用于预防或改善压制猕猴桃提取物的异味损伤的组合物

    公开(公告)号:KR1020070092497A

    公开(公告)日:2007-09-13

    申请号:KR1020060022721

    申请日:2006-03-10

    Abstract: A composition comprising an extract of Epimedium Koreanum harmless to human body is provided to prevent neuronal damage effectively at a hippocampus CA1 area, thereby capable of preventing or improving ischemic damage disease such as vascular dementia, Alzheimer's disease and stroke. A composition for preventing and treating ischemic damage disease comprises 0.001-99.99 wt.% of an extract of Epimedium Koreanum prepared by using at least one solvent selected from the group consisting of water, C1-4 alcohol, hexane, ethyl acetate and dichloromethane as an effective ingredient.

    Abstract translation: 提供包含对人体无害的淫羊藿提取物的组合物以在海马CA1区域有效地防止神经元损伤,由此能够预防或改善缺血性损伤疾病如血管性痴呆,阿尔茨海默病和中风。 用于预防和治疗缺血性损伤疾病的组合物包含通过使用至少一种选自水,C 1-4醇,己烷,乙酸乙酯和二氯甲烷的溶剂作为制备的淫羊藿提取物的0.001-99.99重量% 有效成分。

    에스시탈로프람을 포함하는 허혈성 뇌질환 예방 또는 개선용 약학조성물
    6.
    发明公开
    에스시탈로프람을 포함하는 허혈성 뇌질환 예방 또는 개선용 약학조성물 无效
    用于预防或改善含有ESCITALOPRAM的异常脑疾病的药理学组合物

    公开(公告)号:KR1020100054452A

    公开(公告)日:2010-05-25

    申请号:KR1020080113389

    申请日:2008-11-14

    Abstract: PURPOSE: A pharmaceutical composition containing escitalopram is provided to prevent neural cell damage in a CA1 area and to prevent or treat ischemic brain diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating ischemic a brain disease contains escitalopram. Ischemic brain disease is thrombosis, embolism, transient ischemic attack, cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, white matter dyslipidemia, or lacune. The administering of escitalopram prevents or treats ischemic brain diseases. A pharmaceutical composition for preventing or treating brain disease contains escitalopram and a pharmaceologically acceptable carrier or excipient. The pharmaceutically acceptable carrier or excipient is water, dextrin, or a saline solution. The composition is used in the form of plasters, granules, lotions, powders, syrups, liquids and solutions, aerosols, ointments, fluid extract, emulsion, suspensions, infusions, tablets, injections, capsules, or pills.

    Abstract translation: 目的:提供含有依他普仑的药物组合物,以防止CA1区域的神经细胞损伤,并预防或治疗缺血性脑病。 构成:用于预防或治疗缺血性脑病的药物组合物含有依他普仑。 缺血性脑病是血栓形成,栓塞,短暂性脑缺血发作,脑梗塞,脑出血,蛛网膜下腔出血,白质血脂异常,或泪液。 依他普仑的给药预防或治疗缺血性脑病。 用于预防或治疗脑疾病的药物组合物含有依他普仑和药物学上可接受的载体或赋形剂。 药学上可接受的载体或赋形剂是水,糊精或盐水溶液。 组合物以膏药,颗粒剂,洗剂,粉剂,糖浆,液体和溶液,气溶胶,软膏,流体萃取物,乳液,悬浮液,输液,片剂,注射剂,胶囊或丸剂的形式使用。

    코엔자임 큐텐을 함유하는 자외선에 의한 피부 손상 개선용마스크팩
    9.
    发明公开
    코엔자임 큐텐을 함유하는 자외선에 의한 피부 손상 개선용마스크팩 无效
    掩蔽包含聚苯乙烯Q10用于改善超紫外线诱发的皮肤损伤

    公开(公告)号:KR1020070120330A

    公开(公告)日:2007-12-24

    申请号:KR1020060054946

    申请日:2006-06-19

    Abstract: A mask pack is provided to inhibit the damage induced by UVB by increasing anti-oxidase such as manganese superoxide dismutase and glutathione peroxidase without causing any skin irritation. A mask pack for improving skin damage caused by UVB comprises 0.1-0.4 parts by weight of coenzyme Q10, 7.0-12.0 parts by weight of glycerin, 0.05-0.3 parts by weight of allantoin, 85-95 parts by weight of purified water, 0.04-0.08 parts by weight of carbomer, and 0.05-0.3 parts by weight of triethanolamine. The pack is a sheet type or a patch type.

    Abstract translation: 提供面膜包以通过增加抗氧化酶如锰超氧化物歧化酶和谷胱甘肽过氧化物酶而不引起任何皮肤刺激来抑制UVB引起的损伤。 用于改善由UVB引起的皮肤损伤的口罩包含0.1-0.4重量份辅酶Q10,7.0-12.0重量份甘油,0.05-0.3重量份尿囊素,85-95重量份净化水,0.04 -0.08重量份的卡波姆和0.05-0.3重量份的三乙醇胺。 包装是纸张类型或补丁类型。

    신경세포 보호 효능을 갖는 오리나무더부살이 추출물을포함하는 조성물
    10.
    发明公开
    신경세포 보호 효능을 갖는 오리나무더부살이 추출물을포함하는 조성물 失效
    包含提取神经细胞活性的BOSCHNIAKIA ROSSICA提取物的组合物

    公开(公告)号:KR1020050082176A

    公开(公告)日:2005-08-23

    申请号:KR1020040010528

    申请日:2004-02-18

    Abstract: 본 발명은 신경세포 보호 효능을 갖는 오리나무더부살이 추출물을 포함하는 조성물에 관한 것으로서, 상세하게는 본 발명의 오리나무더부살이 추출물은 뇌허혈에 민감하다고 알려져 있는 해마조직 CA1 영역의 신경세포의 손상을 효과적으로 예방할 뿐만 아니라, 뇌허혈에 의한 신경세포사를 억제하며 인체에도 무해하여 부작용을 발생시키지 않으므로, 이를 포함하는 조성물은 뇌허혈성 질환의 예방 및 치료를 위한 의약품 및 건강기능식품으로 유용하게 이용될 수 있다.

Patent Agency Ranking